![](/img/cover-not-exists.png)
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, Bernard, Wanner, Christoph, Lachin, John M., Fitchett, David, Bluhmki, Erich, Hantel, Stefan, Mattheus, Michaela, Devins, Theresa, Johansen, Odd Erik, Woerle, Hans J., Broedl, Uli C., InzucchiLanguage:
english
Journal:
New England Journal of Medicine
DOI:
10.1056/NEJMoa1504720
Date:
September, 2015
File:
PDF, 537 KB
english, 2015